Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones
| AMIX Stock | 3.15 0.20 5.97% |
Slightly above 63% of Autonomix Medical,'s investor base is looking to short. The analysis of overall sentiment of trading Autonomix Medical, Common stock suggests that many investors are alarmed at this time. Autonomix Medical,'s investing sentiment can be driven by a variety of factors including economic data, Autonomix Medical,'s earnings reports, geopolitical events, and overall market trends.
Autonomix |
First-in-class catheter-based sensing and ablation technology that targets neural signals that indicate pain or disease and destroys them at the source Positive 7-day topline results from first five lead-in patients of the ongoing proof-of-concept human clinical trial in pain associated with pancreatic cancer 46-week follow-up data expected before end of Q3 CY2024 and topline data from the trial expected 1H CY2025 THE WOODLANDS, TX, Aug. 13, 2024 -- Autonomix Medical, Inc
Read at finance.yahoo.com
 |
Autonomix Medical, Fundamental Analysis
We analyze Autonomix Medical,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Autonomix Medical, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Autonomix Medical, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Autonomix Medical, is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Autonomix Medical, Common Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Autonomix Medical, stock to make a market-neutral strategy. Peer analysis of Autonomix Medical, could also be used in its relative valuation, which is a method of valuing Autonomix Medical, by comparing valuation metrics with similar companies.
Peers
Autonomix Medical, Related Equities
Additional Tools for Autonomix Stock Analysis
When running Autonomix Medical,'s price analysis, check to measure Autonomix Medical,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical, is operating at the current time. Most of Autonomix Medical,'s value examination focuses on studying past and present price action to predict the probability of Autonomix Medical,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical,'s price. Additionally, you may evaluate how the addition of Autonomix Medical, to your portfolios can decrease your overall portfolio volatility.